5 shares to profit from a stronger US dollar in 2017

Nanosonics Ltd (ASX:NAN) and Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) may deliver strong returns in 2017.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The arrival of Donald Trump as US president-elect has set the talking heads across the business media into over drive with predictions and analysis as to what President Trump may mean for the ASX and equity markets.

In the interests of brevity and clarity I've summarised below what I think investors should expect in the years ahead due to the Trump effect.

  • Tax cuts
  • Construction
  • Healthcare reform
  • Stronger U.S. dollar

I won't follow some pundits in suggesting the U.S. dollar is set to rocket under Trump's fiscal loosening, but I think it a sensible expectation that it could appreciate around 10% over the Australian dollar during the course of 2017.

This would take the Australian dollar to a level where it buys around 68-70 U.S. cents and will support ASX companies with substantial U.S dollar earnings. Below I have five to consider for forward-thinking investors.

Sirtex Medical Limited (ASX: SRX) is the liver cancer treatment business that is growing at double-digit rates mainly thanks to the strength of sales in its core U.S. market. Shares sell for $28.05, which looks good value, especially when you consider the potential kick ahead when the company releases the results of several clinical trials over 2017.

Magellan Financial Group Ltd (ASX: MFG) is the international equities manager that is a big beneficiary of a stronger U.S. dollar and equity markets in 2017. Moreover, it continues to deliver strong retail and institutional inflows and I expect it will reveal a big jump in total funds under management in early December. At $21.85 with a trailing 4% yield the shares look good value to me.

ResMed Inc. (CHESS) (ASX: RMD) offers investors direct exposure to a stronger U.S. dollar and continues to deliver consistent growth in revenues and earnings. Its margins have also been under pressure due to recent U.S. healthcare reforms that may be reversed under a Republican government in North America. The stock also looks decent value at $7.85.

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) also operates in the sleep apnea space with a lot of U.S. dollar earnings thanks to the success of its operations in the world's largest healthcare market. Much of its foreign currency exposure is hedged, however, with the underlying business producing some exceptional growth it's a business to watch.

Nanosonics Ltd (ASX: NAN) is the hospital disinfectant equipment business that is growing sales strongly to public and private hospitals in the North America. In financial year 2016 it more than doubled sales to U.S. hospitals with momentum reportedly carrying on into the new financial year. It ticks the boxes as an exciting growth prospect, although with shares selling for $3.19 on a market value close to $1 billion it seems like there are some great expectations already factored into the price.

Importantly, all of these businesses have the potential to perform well over the long term irrespective of who occupies the White House or what direction the U.S. dollar takes in the years ahead. However, if Trump's fiscal policies boost inflation and lead to a higher U.S. dollar they may do especially well.

Motley Fool contributor Tom Richardson owns shares of Magellan Financial Group, ResMed Inc., and Sirtex Medical Limited. The Motley Fool Australia owns shares of Nanosonics Limited.   You can find Tom on Twitter @tommyr345 We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »